Loading
institutionsInstitution
Fox Chase Cancer Center
Philadelphia's free-standing cancer centre, where the Philadelphia chromosome, the two-hit hypothesis and hepatitis B were discovered.
Also called: Fox ChaseTemple Health Fox Chase
Overview
Formed in 1974 from the American Oncologic Hospital (1904) and the Institute for Cancer Research (1927), Fox Chase has held NCI comprehensive designation since 1974 and joined Temple University Health System in 2012. Its scientific record is exceptional: David Hungerford co-discovered the Philadelphia chromosome in 1960, Alfred Knudson proposed the two-hit hypothesis of tumour suppressor genes in 1971, Baruch Blumberg identified hepatitis B and developed its vaccine (Nobel Prize 1976), a cornerstone of liver cancer prevention, and Beatrice Mintz pioneered transgenic mice. Clinical strengths today include kidney and prostate cancer, hereditary cancer risk assessment and radiation oncology.
Location
Philadelphia, PA, US
Type
cancer center · Temple University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#112 · 37 points (0 Newsweek + 15 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Fox Chase Cancer Center, including child institutions. 768 works · 13,099 citations · 62% open access · 13% clinical trials · 1% reviews.
Oncology works per year
1532022
1602023
1772024
1622025
1162026
Most works
- Hossein Borghaei78 works
- Anthony J. Olszanski44 works
- Jennifer Barsky Reese35 works
- Efrat Dotan32 works
- Luis G Paz-Ares26 works
- Jeffrey M. Farma25 works
- Stephen V. Liu24 works
- Elizabeth A. Handorf23 works
- Edna Cukierman23 works
- Martin Joseph Edelman23 works
Most cited
- Kidney cancer
- Hereditary cancer risk assessment
- Radiation oncology
Similar pages
- InstitutionUC Davis Comprehensive Cancer Center
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH), Prostate cancer.
- Key paperThe risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing, National Cancer Institute (NIH), Prostate cancer.
- IdeaStore adult-onset cancer gene results from newborn genomes and disclose at 18
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
- IdeaFamily history collected by app and matched to testing criteria automatically
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
- IdeaA chatbot for pre-test genetic counselling so counsellors see only who needs them
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
- TargetCDKN1A
Shares Retinoblastoma, Renal cell carcinoma, Hepatocellular carcinoma.
- IdeaGo back to families of women who died of ovarian cancer and offer BRCA testing
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
- IdeaOffer everyone at 30 a test for the cancer genes that matter
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.